Release Date:  April 10, 2002


National Institute of Allergy and Infectious Diseases

Receipt Date: July 15, 2002


The Division of Acquired Immune Deficiency Syndrome (DAIDS) of the National 
Institute of Allergy and Infectious Diseases (NIAID), National Institutes of 
Health (NIH), is recompeting their current contract with Social and 
Scientific Systems, Inc., Contract Number N01-AI-65275.  This solicitation 
will be a 100% Small Business Set-Aside, NAICS Code 541710, 500 employees. 

This new contract will be awarded as a performance-based contract with the 
emphasis being on the contractor's ability to provide rapid response to 
requests for support to the Division of AIDS.  The DAIDS is seeking capable 
small business organizations having regulatory, clinical and technical 
expertise and facilities to provide the Regulatory Affairs Branch (RAB) in 
DAIDS with regulatory and technical support to facilitate management of 
regulatory aspects of DAIDS-sponsored clinical trials.

This critical contract will exist within a complex research environment and a 
consortium of multiple clinical trials groups, which are increasingly 
international in scope. International research is predominantly conducted in 
countries with high prevalence of HIV/AIDS. The clinical trials networks to 
be supported include, but are not limited to: HIV Vaccine Trials Network 
(HVTN); HIV Prevention Trials Network (HPTN); Adult AIDS Clinical Trials 
Group (AACTG); Pediatric AIDS Clinical Trials Group (PACTG); Evaluation of 
Subcutaneous Proleukin in a Randomized International Trial (ESPRIT); The 
Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA); and 
Acute HIV Infection and Early Disease Research Program (AIEDRP). These 
networks interact with a complex research environment composed of, but not 
limited to, clinical investigators and their institutions, the statistical 
and data analysis centers, operational centers of the networks, the Food and 
Drug Administration (FDA), the Office of Human Research Protection (OHRP), 
the Fogarty International Center (FIC), the pharmaceutical industry, local 
and national Internal Review Board/Ethics Committees, patients with HIV/AIDS 
and their advocates, populations at risk for HIV infection, and the DAIDS' 
scientific and administrative personnel. These networks make key decisions 
about HIV/AIDS treatment and prevention research and conduct numerous 
clinical trials of all phases. 

The clinical research organization must: (1) provide regulatory, clinical and 
technical expertise to enable DAIDS to fulfill its responsibilities as a 
sponsor of a large portfolio of Investigational New Drug (IND) Applications 
and other large clinical trials not conducted under IND; (2) manage the 
Serious Adverse Experience (SAE) System for both IND and non-IND studies of 
all phases; (3) provide technical ability to write concept sheet and protocol 
review summaries and related letters for DAIDS; (4) maintain the protocol 
registration and informed consent review systems; (5) develop in 
collaboration with DAIDS and the pharmaceutical industry lists of risks 
associated with approved/investigational drugs/vaccines used in DAIDS-
sponsored clinical trials; (6) assist or lead in negotiation of clinical 
trials agreements with pharmaceutical collaborators; (7) coordinate and 
prepare for meetings and conference calls with the FDA, OHRP or other groups 
collaborating with the networks and other such activities as may be necessary 
to successfully conduct DAIDS-sponsored clinical trials; (8) establish and 
maintain a computerized information system to produce reports and track 
existing and evolving information related to major responsibilities of the 
contract; (9) provide extensive international travel of contractor staff and 
set up international conference calls for the purpose of providing updated 
information about regulatory issues and site regulatory responsibilities; 
and, (10) participate in electronic communication between DAIDS and clinical 
trials groups' operational offices and sites for the purpose of information 

It is anticipated that the period of performance for this contract will be a 
total of seven years to be award as a three-year base period with two, two-
year, options. Any responsible Offeror may submit a proposal that will be 
considered by the Government.  This advertisement does not commit the 
Government to award a contract.  No collect calls will be accepted. No 
facsimile transmissions will be accepted.

RFP-NIH-NIAID-DAIDS-03-26 may be accessed through the NIAID Contract 
Management Branch (CMB) Home Page at http://www.niaid.nih.gov/contract and 
was posted on FedBizOpps. 

Contracting Office Address:

National Institutes of Health
National Institutes of Allergy and Infectious Diseases
Contract Management Branch 
6700-B Rockledge Drive
Room 2230, MSC 7612 
Bethesda, MD, 20892-7612

Point of Contact: 
Nancy Hershey, Contract Specialist, Phone 301-496-0193, Fax 301-402-0972, 
Email nh11x@nih.gov
Barbara Shadrick, Senior Contracting Officer, Phone 301-496-7288, Fax 301-
402-0972, Email bs92y@nih.gov

This announcement does not commit the Government to award a contract. No 
collect calls will be accepted.

Return to Volume Index

Return to NIH Guide Main Index

Office of Extramural Research (OER) - Home Page Office of Extramural
Research (OER)
  National Institutes of Health (NIH) - Home Page National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
  Department of Health and Human Services (HHS) - Home Page Department of Health
and Human Services (HHS)
  USA.gov - Government Made Easy

Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.